| The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state N Alhawiti, KL Burbury, FA Kwa, CJ O'Malley, P Shuttleworth, M Alzard, ... Thrombosis research 145, 54-64, 2016 | 71 | 2016 |
| New generation drugs for treatment of multiple myeloma F Alanazi, FAA Kwa, G Burchall, DE Jackson Drug discovery today 25 (2), 367-379, 2020 | 44 | 2020 |
| Chromatin modifying agents–the cutting edge of anticancer therapy FAA Kwa, A Balcerczyk, P Licciardi, A El-Osta, TC Karagiannis Drug discovery today 16 (13-14), 543-547, 2011 | 37 | 2011 |
| Ponatinib tyrosine kinase inhibitor induces a thromboinflammatory response A Hamadi, AP Grigg, G Dobie, KL Burbury, AP Schwarer, FA Kwa, ... Thrombosis and haemostasis 119 (07), 1112-1123, 2019 | 30 | 2019 |
| Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy FAA Kwa, TR Thrimawithana Drug Discovery Today 19 (9), 1387-1393, 2014 | 29 | 2014 |
| Midkine: the who, what, where, and when of a promising neurotrophic therapy for perinatal brain injury E Ross-Munro, F Kwa, J Kreiner, M Khore, SL Miller, M Tolcos, B Fleiss, ... Frontiers in neurology 11, 568814, 2020 | 26 | 2020 |
| Recent advances in the management of diabetic retinopathy N Dulull, F Kwa, N Osman, U Rai, B Shaikh, TR Thrimawithana Drug Discovery Today 24 (8), 1499-1509, 2019 | 21 | 2019 |
| Influence of natural and synthetic histone deacetylase inhibitors on chromatin PV Licciardi, FAA Kwa, K Ververis, N Di Costanzo, A Balcerczyk, ML Tang, ... Antioxidants & redox signaling 17 (2), 340-354, 2012 | 21 | 2012 |
| Manipulating the epigenome for the treatment of disorders with thrombotic complications FAA Kwa, DE Jackson Drug discovery today 23 (3), 719-726, 2018 | 16 | 2018 |
| L-Sulforaphane confers protection against oxidative stress in an in vitro model of age-related macular degeneration NK Dulull, DA Dias, TR Thrimawithana, FAA Kwa Current Molecular Pharmacology 11 (3), 237-253, 2018 | 14 | 2018 |
| Investigation of the biological properties of Cinnulin PF in the context of diabetes: mechanistic insights by genome-wide mRNA-Seq analysis H Rafehi, K Ververis, A Balcerczyk, M Ziemann, J Ooi, S Hu, FAA Kwa, ... Pathobiology of Aging & Age-related Diseases 2 (1), 11905, 2012 | 11 | 2012 |
| Molecular approaches for the treatment and prevention of Friedreich's ataxia W Yang, B Thompson, FAA Kwa Drug Discovery Today 27 (3), 866-880, 2022 | 6 | 2022 |
| Combination treatment of p53-null HL-60 cells with histone deacetylase inhibitors and chlorambucil augments apoptosis and increases BCL6 and p21 gene expression FAA Kwa, MF Cole-Sinclair, MK Kapuscinski Current Molecular Pharmacology 12 (1), 72-81, 2019 | 6 | 2019 |
| Lipidomics reveal the protective effects of a vegetable-derived isothiocyanate against retinal degeneration FA Kwa, NK Dulull, U Roessner, DA Dias, TW Rupasinghe F1000Research 8, 2019 | 6 | 2019 |
| Mimicking the ocular environment for the study of inflammatory posterior eye disorders NK Dulull, TR Thrimawithana, FAA Kwa Drug Discovery Today 22 (2), 440-446, 2017 | 6 | 2017 |
| Preclinical investigations on broccoli-derived sulforaphane for the treatment of ophthalmic disease FAA Kwa, BV Bui, BR Thompson, LN Ayton Drug Discovery Today, 103718, 2023 | 5 | 2023 |
| An overview of Japanese Encephalitis in Australia: trends, impact and interventions FAA Kwa, E Kendal, J Xiao Applied Sciences 13 (16), 9184, 2023 | 4 | 2023 |
| L-sulforaphane Confers Protection against Oxidative Stress in an NK Dulull, DA Dias, TR Thrimawithana, FAA Kwa vitro, 2018 | 4 | 2018 |
| Chlorambucil-sensitive and-resistant lymphoid cells display different responses to the histone deacetylase inhibitor, sodium butyrate FAA Kwa, M Cole-Sinclair, M Kapuscinski Biochemical and biophysical research communications 403 (3-4), 288-292, 2010 | 4 | 2010 |
| Vitamin D receptor (VDR) polymorphisms in chronic lymphocytic leukaemia (CLL) patients. F Kwa, M Kapuscinski, M Cole-Sinclair Blood, The Journal of the American Society of Hematology 110 (11), 4689-4689, 2007 | 2 | 2007 |
